ghk cu clinical trial human skin wound healing randomized GHK-Cu Peptide: Evidence, Safety & Genetic Factors Ghk-cu and skin peptides (topical)

In addition, studies report increased intracellular glutathione (GSH) levels, improved GSH/GSSG ratios, and stabilization of mitochondrial membrane potential

Side effects may temporarily increase with each dose escalation and then subside as adaptation occurs

Preclinical research has demonstrated that GHK-Cu can modulate gene expression associated with collagen synthesis, angiogenesis, inflammation regulation, and antioxidant defense systems

Findings: Studies showed increased collagen production and improved tissue repair mechanisms in experimental models

A., Frolking, S., Wisser, D., and Douglas, E

Preclinical studies have explored GHK-Cu effects in cardiovascular applications, where the peptide demonstrates capacity to reduce atherosclerotic plaque formation in hyperlipidemic mice through anti-inflammatory effects and improved endothelial function